MELISSA SUE MERICLE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PHOENIX, AZ NPI 1760151328

General Payments — all program years on this page

$1,863.12

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $873.41 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $773.4219
Education $99.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $34.542
2022 $286.714
2023 $668.4614
2024 $873.4120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1099942123 ImmunoGen, Inc. $125.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105239559 AstraZeneca Pharmaceuticals LP $17.12 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105543565 AstraZeneca Pharmaceuticals LP $30.02 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110815128 Eisai Inc. $27.20 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115919052 GlaxoSmithKline, LLC. $25.39 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116303667 GlaxoSmithKline, LLC. $19.95 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116638646 GlaxoSmithKline, LLC. $17.17 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116691579 GlaxoSmithKline, LLC. $124.99 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126838166 Genmab U.S., Inc. $105.27 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126838168 Genmab U.S., Inc. $29.58 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126838170 Genmab U.S., Inc. $34.82 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126838172 Genmab U.S., Inc. $33.02 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126838174 Genmab U.S., Inc. $31.71 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128504834 PROGENICS PHARMACEUTICALS, INC. $24.44 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131995849 SEAGEN INC. $99.99 10/16/2024 Education Undisputed 01/23/2026 View at CMS
1139552349 Astellas Pharma US Inc $24.65 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141440971 SOBI, INC $23.30 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141714150 Merck Sharp & Dohme LLC $25.89 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143497018 Aveo Pharmaceuticals, Inc. $17.05 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144722959 TerSera Therapeutics LLC $36.85 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.